Cases of Interest
Media Tech Law Blog
Sign Up for Email Alerts
Chief Marketing Officer
Business Pressures, Conflict Potential Prompt Firm to Take Sides in Drug Company IP Cases
October 26, 2010 |
New York Law Journal
Loeb & Loeb LLP
is profiled on the firm's strategy to move away from representing generic drug companies in order to create fewer conflicts when pitching brand-name drug companies for intellectual property work.
is quoted on the thinking behind this strategy, spurred by today's increasingly consolidated pharmaceutical industry.
David S. Schaefer
Life Sciences Patent Litigation and Counseling
Patent Litigation and Counseling
This Web site may constitute "Attorney Advertising" under the New York Rules of Professional Conduct and under the law of other jurisdictions.
Your use of our Web site or its facilities constitutes your acceptance of the
, which are accessible in the link at the bottom left of this page.